Development of a fluorescence polarization immunoassay (FPIA) for the quantitative determination of paclitaxel

Autor: Michel Pagé, C. Bicamumpaka

Publikováno v: Journal of Immunological Methods. 212:1-7

We have developed a fluorescence polarization immunoassay (FPIA) for the quantitative determination of paclitaxel in serum, crude Taxus extracts and Erwinia taxi culture medium. To achieve this, we used an antipaclitaxel monoclonal antibody and an FI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3f7b0ebc64f994ef2a84621523c9210
https://doi.org/10.1016/s0022-1759(97)00183-x

Paclitaxel stimulates melanogenesis in B16-F1 melanoma cells

Autor: C, Bicamumpaka, M, Pagé

Publikováno v: Anticancer research. 18(6A)

Upon incubation with paclitaxel, B16-F1 melanoma cells showed a flattening and darkening of their cytoplasm. By electron microscopy analysis, an increase in the number of melanosomes associated with an increase of their melanin content was observed.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ab8bf7d323aa037f4f541691bfd83bb9
https://pubmed.ncbi.nlm.nih.gov/9891452

In vitro cytotoxicity of paclitaxel-transferrin conjugate on H69 cells

Autor: Michel Pagé, C Bicamumpaka

Publikováno v: Oncology reports. 5(6)

Transferrin is a serum glycoprotein involved in iron transport. Transferrin acts also in cell growth regulation through membrane receptors. The number of transferrin receptors is increased in tumor and other rapidly dividing cells. This renders trans

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::639cf5d604d83b1d15c3fbd6cf147857
https://pubmed.ncbi.nlm.nih.gov/9769372

Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification.

Autor: Thompson EF; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada., Huvila J; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada.; Department of Pathology, University of Turku, Turku University Hospital, Turku, Finland., Jamieson A; Department of Gynaecology and Obstetrics and Division of Gynaecologic Oncology, University of British Columbia, Vancouver, BC, Canada., Leung S; Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada., Lum A; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada., Offman S; Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, NS, Canada., Lytwyn A; Department of Pathology and Molecular Medicine, McMaster University and The Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada., Sur ML; Department of Pathology and Molecular Medicine, McMaster University and The Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada., Hoang L; Department of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada., Irving J; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., van der Westhuizen N; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Morin C; Pathology Department, Centre Hospitalier Universitaire de Québec at Laval University and L'Hôtel-Dieu de Québec, Quebec, QC, Canada., Bicamumpaka C; Department of Pathology, University of Manitoba, Winnipeg, MB, Canada., Azordegan N; Department of Pathology, University of Manitoba, Winnipeg, MB, Canada., Gougeon F; Department of Molecular Biology, Medical Biochemistry and Pathology, Centre Hospitalier Universitaire de Montréal at Université de Montréal, Montreal, QC, Canada., Ennour-Idrissi K; Department of Molecular Biology, Medical Biochemistry and Pathology, Centre Hospitalier Universitaire de Québec at Université de Laval, Quebec, QC, Canada., Senz J; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada., McConechy MK; Canexia Health, Vancouver, BC, Canada., Aguirre-Hernandez R; Canexia Health, Vancouver, BC, Canada., Lui V; Faculty of Science, University of British Columbia, Vancouver, BC, Canada., Kuo C; Obstetrics, Gynecology and Reproductive Sciences Residency Program, University of Manitoba, Winnipeg, MB, Canada., Bell C; MD Undergraduate Program, University of Saskatchewan, Saskatoon, SK, Canada., Salisbury T; Department of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada., Lawson J; MD undergraduate program, University of British Columbia, Vancouver, BC, Canada., He E; MD undergraduate program, University of British Columbia, Vancouver, BC, Canada., Wang S; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada., Chiu D; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada., Kean S; Division of Gynecologic Oncology, University of Manitoba, Winnipeg, MB, Canada., Samouëlian V; Department of Obstetrics and Gynecology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Salvador S; Division of Gynecologic Oncology, Lady Davis Institute of Research, Jewish General Hospital, McGill University, Montreal, QC, Canada., Gotlieb W; Division of Gynecologic Oncology, Lady Davis Institute of Research, Jewish General Hospital, McGill University, Montreal, QC, Canada., Helpman L; Division of Gynecologic Oncology, McMaster University and The Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada., Scott S; Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Dalhousie University, Halifax, NS, Canada., Wohlmuth C; Department of Obstetrics and Gynecology, Paracelsus Medical University, Salzburg, Austria.; Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of Toronto, Toronto, ON, Canada., Vicus D; Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of Toronto, Toronto, ON, Canada., Plante M; Department of Obstetrics, Gynecology and Reproduction, Centre Hospitalier Universitaire de Québec, L'Hôtel-Dieu de Québec, Laval University, Quebec, QC, Canada., Talhouk A; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada., Huntsman D; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada., Parra-Herran C; Department of Laboratory Medicine and Pathobiology University of Toronto and Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Kinloch M; Department of Pathology and Laboratory Medicine, University of Saskatchewan and Saskatoon City Hospital, Saskatoon, SK, Canada., Grondin K; Pathology Department, Centre Hospitalier Universitaire de Québec at Laval University and L'Hôtel-Dieu de Québec, Quebec, QC, Canada., Gilks CB; Department of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada. blake.gilks@vch.ca., McAlpine JN; Department of Gynaecology and Obstetrics and Division of Gynaecologic Oncology, University of British Columbia, Vancouver, BC, Canada.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2022 Dec; Vol. 35 (12), pp. 1974-1982. Date of Electronic Publication: 2022 Oct 14.

Oncocytic renal cell carcinoma with immunohistochemical properties of renal oncocytoma.

Autor: Mai KT; Department of Laboratory Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada. ktmai@ottawahospital.on.ca, Bicamumpaka C, Robertson SJ, Marginean CE, Belanger EC

Publikováno v: Pathology, research and practice [Pathol Res Pract] 2009; Vol. 205 (2), pp. 119-24. Date of Electronic Publication: 2008 Oct 22.